ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
Journal of Hepatology
◽
10.1016/j.jhep.2005.12.011
◽
2006
◽
Vol 44
(4)
◽
pp. 671-678
◽
Cited By ~ 68
Author(s):
Vincent G. Bain
◽
Kelly D. Kaita
◽
Eric M. Yoshida
◽
Mark G. Swain
◽
E. Jenny Heathcote
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Antiviral Activity
◽
Human Albumin
◽
Interferon Alfa
◽
Phase 2
◽
Genotype 1
◽
Phase 2 Study
◽
Chronic Hepatitis C Patients
◽
Recombinant Human Albumin
Download Full-text
Related Documents
Cited By
References
Rg-101 in Combination With 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High Virologic Response Rates in Treatment Naïve Genotype 1 and 4 Chronic Hepatitis C Patients: Interim Results from a Randomised, Multicenter, Phase 2 Study
Journal of Hepatology
◽
10.1016/s0168-8278(16)01665-2
◽
2016
◽
Vol 64
(2)
◽
pp. S159
◽
Cited By ~ 1
Author(s):
G. Horvath
◽
G. Papatheodoridis
◽
M. Fabri
◽
M. Makara
◽
P. Grint
◽
...
Keyword(s):
Chronic Hepatitis
◽
Virologic Response
◽
Phase 2
◽
Genotype 1
◽
Direct Acting Antiviral
◽
Multicenter Phase
◽
Phase 2 Study
◽
Treatment Naïve
◽
Direct Acting
◽
Chronic Hepatitis C Patients
Download Full-text
24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia
Korean Journal of Gastroenterology
◽
10.4166/kjg.2010.56.1.33
◽
2010
◽
Vol 56
(1)
◽
pp. 33
◽
Cited By ~ 3
Author(s):
Sung Soo Moon
◽
Hyoun Gu Kang
◽
Jeong Ah Seo
◽
Eun Uk Jung
◽
Sang Heon Lee
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Virological Response
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Rapid Virological Response
◽
Genotype 1
◽
Pegylated Interferon Alfa
◽
Chronic Hepatitis C Patients
Download Full-text
838 Pegylated Interferon Alfa, Nitazoxanide, Telapravir, Ribavirin, in Genotype 1 Undergoing Prior Experienced Chronic Hepatitis C Patients-a Randomized Placebo Control Clinical Pilot Trial (I N T R I G U E C) Interim
Gastroenterology
◽
10.1016/s0016-5085(12)63615-4
◽
2012
◽
Vol 142
(5)
◽
pp. S-932
◽
Cited By ~ 1
Author(s):
Patrick Basu
◽
Thankam Nair
◽
Sakina Farhat
◽
Sajith Foustin
◽
Lynn P. Ang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Pilot Trial
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Placebo Control
◽
Genotype 1
◽
Pegylated Interferon Alfa
◽
Chronic Hepatitis C Patients
Download Full-text
Pegylated Interferon Alfa, Nitazoxanide, Telaprevir, Ribavirin, in Genotype 1 Undergoing Prior Experienced Chronic Hepatitis C Patients - A Randomized Placebo Control Clinical Pilot Trial (INTRIGUE-C)
The American Journal of Gastroenterology
◽
10.14309/00000434-201210001-00363
◽
2012
◽
Vol 107
◽
pp. S154
Author(s):
Patrick Basu
◽
N. Shah
◽
S. Farhat
◽
R. Siriki
◽
Md Rahman
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Pilot Trial
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Placebo Control
◽
Genotype 1
◽
Pegylated Interferon Alfa
◽
Chronic Hepatitis C Patients
Download Full-text
18 A phase 2 study to assess antiviral response, safety, and pharmacokinetics of albuferon™ in IFN-α NA1VE subjects with genotype 1 chronic hepatitis C
Journal of Hepatology
◽
10.1016/s0168-8278(05)81430-8
◽
2005
◽
Vol 42
◽
pp. 9
◽
Cited By ~ 2
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Antiviral Response
◽
Phase 2
◽
Genotype 1
◽
Phase 2 Study
Download Full-text
Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study
Journal of Hepatology
◽
10.1016/j.jhep.2007.02.018
◽
2007
◽
Vol 47
(1)
◽
pp. 51-59
◽
Cited By ~ 31
Author(s):
Robert G. Gish
◽
Sanjeev Arora
◽
K. Rajender Reddy
◽
David R. Nelson
◽
Christopher O’Brien
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Virological Response
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Phase 2
◽
Phase 2 Study
◽
Pegylated Interferon Alfa
◽
Randomized Phase 2
Download Full-text
1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
Journal of Hepatology
◽
10.1016/s0168-8278(12)61114-3
◽
2012
◽
Vol 56
◽
pp. S434
◽
Cited By ~ 3
Author(s):
S. Curtis
◽
S. Cure
◽
S. Gavart
◽
L. Dearden
◽
J. Fleischmann
◽
...
Keyword(s):
Chronic Hepatitis
◽
Cost Effectiveness
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Genotype 1
◽
Pegylated Interferon Alfa
◽
The Cost
◽
Chronic Hepatitis C Patients
Download Full-text
Open-label phase 2 study of faldaprevir, deleobuvir and ribavirin in Japanese treatment-naive patients with chronic hepatitis C virus genotype 1 infection
Hepatology Research
◽
10.1111/hepr.12535
◽
2015
◽
Vol 46
(3)
◽
pp. E189-E193
Author(s):
Hiroshi Yatsuhashi
◽
Nobuyoshi Kodani
◽
Hiroyuki Ugai
◽
Masao Omata
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Phase 2
◽
Genotype 1
◽
Virus Genotype
◽
Open Label
◽
Phase 2 Study
◽
Chronic Hepatitis C Virus
◽
Open Label Phase
◽
Treatment Naïve
Download Full-text
4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C
Journal of Hepatology
◽
10.1016/s0168-8278(09)60006-4
◽
2009
◽
Vol 50
◽
pp. S4
◽
Cited By ~ 49
Author(s):
P. Kwo
◽
E. Lawitz
◽
J. McCone
◽
E. Schiff
◽
J. Vierling
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Phase 2
◽
Genotype 1
◽
Phase 2 Study
◽
Treatment Naïve
◽
Peginterferon Alfa
Download Full-text
PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)
Value in Health
◽
10.1016/j.jval.2011.08.236
◽
2011
◽
Vol 14
(7)
◽
pp. A274
◽
Cited By ~ 1
Author(s):
E. Nikoglou
◽
S. Humphreys
◽
A. El khoury
◽
S.A. Ferrante
◽
C. O' Regan
Keyword(s):
Chronic Hepatitis
◽
Cost Effectiveness
◽
Hepatitis C
◽
National Health Service
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Genotype 1
◽
Trial Analysis
◽
Pegylated Interferon Alfa
◽
Chronic Hepatitis C Patients
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close